[1]
R. RAHMAH, “Government-Use License and Stem Cell-Based Pharmaceuticals Patent: Equitable Access to Covid-19 Medications”, Utopía y prax. latinoam., vol. 25, no. 1, pp. 94-110, Sep. 2020.